𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacological reactivation of mutant p53: from protein structure to the cancer patient

✍ Scribed by Wiman, K G


Book ID
109972383
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
455 KB
Volume
29
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Detection of antibodies against the cell
✍ L. V. Crawford; D. C. Pim; R. D. Bulbrook πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 French βš– 658 KB

## Abstract Antibodies reacting with the host protein p53 were found in the sera of patients with primary or secondary carcinoma of the breast. Fourteen out of the 155 sera from breast cancer patients tested were positive for anti‐p53 antibodies (9%) and no positives were detected among 164 control

Inactivation of the p53 protein in cell
✍ Christoph Barnas; Ghyslaine Martel-Planche; Yoichi Furukawa; Monica Hollstein; R πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 225 KB πŸ‘ 2 views

Alteration of the p53 gene is thought to be important in the early stages of human esophageal cancers, but how this confers a selective advantage to esophageal cancer cells is unknown. In this report, we analyzed 9 cell lines derived from human esophageal cancers (TE-1, TE-3, TE-6, TE-7, TE-9, TE-10

The road to the discovery of the p53 pro
✍ Arnold J. Levine πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 304 KB πŸ‘ 1 views

The p.53 gene and its protein have acquired major importance in the understanding of the origins of neoplasia in human beings. Of all carcinomas, 60-65% contain mutations at thep.53 locus (Levine, 1993) and these mutations take a characteristic form; one p.53 allele usually sustains a point mutation